Idiopathic Pulmonary Fibrosis (IPF)

DBCOND0031843Immune System DiseasesRespiratory Tract Diseases

Idiopathic Pulmonary Fibrosis (IPF) is the indication for 5 drugs in DrugBank. It is covered by 7 curated, structured indications.

Also known as
idiopathic Pulmonary Fibrosis · IPF · Idiopathic Pulmonary Fibrosis(IPF) · Pulmonary Fibrosis, Idiopathic · Pulmonary Fibroses, Idiopathic
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM000646522ICD-10J84.11SNOMED CT129459004MedDRA10001892UMLSC0085786

What you can answer from here — as of November 01, 2026

5Indicated drugsWith each drug's targets and mechanism
Listed above
7Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
360Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Contraindicated drugDrugs whose labels contraindicate them in this condition
Sign in
2Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Idiopathic Pulmonary Fibrosis (IPF) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In